Professor Malcolm Richardson PhD, FSB, FRCPath, FISSE
Malcolm Richardson is Director of the Mycology Reference Centre, Wythenshawe Hospital, Manchester and has an affiliate appointment at the University of Manchester as a Honorary Professor of Medical Mycology. Prior to these positions he was an Associate Professor of Medical Mycology, University of Helsinki, Finland. He is an elected Fellow of the Royal College of Pathologists (UK) and of the Society of Biology (UK). His clinical and laboratory investigations have focused on the pathogenicity, diagnosis and epidemiology of superficial and systemic fungal infections. More recently he has applied his diagnostic experience to investigating the role of moulds in “sick building syndrome”. In recognition of this he has recently been elected as President of the Institute of Specialist Surveys and Engineers. He has published over 350 original articles, book chapters, reviews and policy documents, and is the author or editor of fifteen mycological textbooks and handbooks, including Fungal Infection: Diagnosis and Management, 4th Edition (2012), The Pocket Guide to Fungal infection, 2nd Edition (2006), Therapeutic Guidelines in Systemic Fungal Infection, 4th Edition (2007), and Fungal Infection and Critical Care Medicine (2008).
His professional duties include being Editor-in-Chief of Critical Reviews in Microbiology. Critical Reviews in Microbiology is delighted to announce that its 2011 Impact Factor increased to 6.270 from 5.345 in 2010. The journal now ranks 13/107 in ISI’s Microbiology category. Previous duties have included being the General Secretary of the International Society of Human and Animal Mycology (ISHAM) (2003-2009). In June 2012 Malcolm Richardson was elected as President-Elect of ISHAM (2012-2015) and will take up the position of ISHAM President in 2015. He is also a mycology consultant for various environmental, pharmaceutical and health care companies.
Most recent contributions to the literature:
Frequency of Pneumocystis jirovecii in sputum from HIV and TB patients in Namibia. Nowaseb V, Gaeb E, Fraczek MG, Richardson MD, Denning DW. J Infect Dev Ctries. 2014 Mar 13;8(3):349-57. doi: 10.3855/jidc.3864.
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW. J Antimicrob Chemother. 2013 Dec 29. [Epub ahead of print]
In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole. Gregson L, Goodwin J, Johnson A, McEntee L, Moore CB, Richardson M, Hope WW, Howard SJ. Antimicrob Agents Chemother. 2013 Nov;57(11):5778-80. doi: 10.1128/AAC.01141-13.
Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. Barrs VR, van Doorn TM, Houbraken J, Kidd SE, Martin P, Pinheiro MD, Richardson M, Varga J, Samson RA. PLoS One. 2013 Jun 14;8(6):e64871. doi: 10.1371/journal.pone.0064871. Print 2013.
Contact:
Mycology Reference Centre
Education and Research Centre
University Hospital of South Manchester
Southmoor Road
Manchester M23 9LT, UK
E-mail: Malcolm.richardson@manchester.ac.uk